Insider Trading25 Sept 2026, 01:20 pm
Mankind Pharma Closes Trading Window for Designated Persons
AI Summary
Mankind Pharma Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in effect from October 01, 2026, and will remain open 48 hours after the declaration of the company's unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The specific date for the Board Meeting to declare these financial results will be communicated separately.
Key Highlights
- Trading window closed for designated persons from October 1, 2026.
- Closure is until 48 hours post Q2 FY27 financial results declaration.
- Adheres to SEBI Insider Trading Regulations and company's code of conduct.
- Board meeting date for results declaration to be announced later.
Price Impact
More from MANKIND